PharmaJet Partner, Institute for Molecular Medicine, Launches Clinical Trial for the First in Human Alzheimer’s DNA Vaccine

PharmaJet® announced that its partner, the Institute for Molecular Medicine was awarded a $12 Million grant from the National Institute on Aging division of the National Institutes of Health.